Main Street Investment Advisors LLC Eli Lilly & CO Transaction History

Main Street Investment Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$592.2 - $792.28 $502,185 - $671,853	848 New	848 $659,000
Q3 2023 Feb 16, 2024	BUY	$434.7 - $599.3 $368,625 - $508,206	848 New	848 $455,000
Q3 2023 Oct 31, 2023	SELL	$434.7 - $599.3 $206,047 - $284,068	-474 Reduced 35.85%	848 $455,000
Q2 2023 Feb 16, 2024	BUY	$350.74 - $468.98 $463,678 - $619,991	1,322 New	1,322 $619,000
Q2 2023 Jul 21, 2023	SELL	$350.74 - $468.98 $9,820 - $13,131	-28 Reduced 2.07%	1,322 $619,000
Q1 2023 Apr 28, 2023	BUY	$310.63 - $364.82 $419,350 - $492,507	1,350 New	1,350 $463,000
Q3 2020 Nov 09, 2020	SELL	$146.22 - $169.13 $2.47 Million - $2.85 Million	-16,861 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $1.61 Million - $1.94 Million	11,838 Added 235.68%	16,861 $2.77 Million
Q1 2020 May 11, 2020	BUY	$119.05 - $147.35 $597,988 - $740,139	5,023 New	5,023 $697,000

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Main Street Investment Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Main Street Investment Advisors LLC with notifications on news.